£1.3M
Morgan Stanley led the seed round to support platform expansion and data science development.
"Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause."
U
Unfabled—United KingdomMorgan Stanley + 6 others